open access

Vol 17, No 5 (2010)
Technology notes
Published online: 2010-09-23
Get Citation

The ‘chest pain kit’ study: A ‘pill in the pocket’ concept to improve the pre-hospital therapy of acute coronary syndrome

Stefan Kralev
Cardiol J 2010;17(5):528-531.

open access

Vol 17, No 5 (2010)
Technology notes
Published online: 2010-09-23

Abstract

The ‘pill in the pocket’ concept is an established therapy for atrial fibrillation. The current guidelines for the management of patients with ST-elevation myocardial infarction endorse the concept that faster time to reperfusion is associated with important reductions in morbidity and mortality. The mechanical reperfusion and outcome of these patients is significantly supported by dual antiplatelet therapy. There is no data comparing the effect of early self-application by the patient (‘pill in the pocket’) versus application by the emergency doctor of dual antiplatelet therapy and a factor Xa inhibitor in case of severe chest pain.
In patients with a high risk of developing an acute coronary syndrome and previously selected by a cardiologist, early self-application of dual antiplatelet therapy and a factor Xa inhibitor (e.g. fondaparinux) immediately after calling the emergency doctor might be of significance in cases of acute coronary syndrome or pulmonary embolism. In particular, in less developed areas where it might take a long time for the emergency doctor to arrive, this ‘pill in the pocket’ concept may be significant. (Cardiol J 2010; 17, 5: 528-531)

Abstract

The ‘pill in the pocket’ concept is an established therapy for atrial fibrillation. The current guidelines for the management of patients with ST-elevation myocardial infarction endorse the concept that faster time to reperfusion is associated with important reductions in morbidity and mortality. The mechanical reperfusion and outcome of these patients is significantly supported by dual antiplatelet therapy. There is no data comparing the effect of early self-application by the patient (‘pill in the pocket’) versus application by the emergency doctor of dual antiplatelet therapy and a factor Xa inhibitor in case of severe chest pain.
In patients with a high risk of developing an acute coronary syndrome and previously selected by a cardiologist, early self-application of dual antiplatelet therapy and a factor Xa inhibitor (e.g. fondaparinux) immediately after calling the emergency doctor might be of significance in cases of acute coronary syndrome or pulmonary embolism. In particular, in less developed areas where it might take a long time for the emergency doctor to arrive, this ‘pill in the pocket’ concept may be significant. (Cardiol J 2010; 17, 5: 528-531)
Get Citation

Keywords

acute coronary syndrome; myocardial infarction chest pain; pill in the pocket

About this article
Title

The ‘chest pain kit’ study: A ‘pill in the pocket’ concept to improve the pre-hospital therapy of acute coronary syndrome

Journal

Cardiology Journal

Issue

Vol 17, No 5 (2010)

Pages

528-531

Published online

2010-09-23

Bibliographic record

Cardiol J 2010;17(5):528-531.

Keywords

acute coronary syndrome
myocardial infarction chest pain
pill in the pocket

Authors

Stefan Kralev

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl